Covered recipient · General Payments record
ROSE BALLARD
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$2,690.87
- Reported across 103 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $872.15 | 33 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $256.74 | 12 |
| BOSTON SCIENTIFIC CORPORATION | $140.40 | 1 |
| PFIZER INC. | $83.54 | 4 |
| UCB, Inc. | $41.61 | 2 |
| Neurelis, Inc. | $41.56 | 2 |
| CATALYST PHARMACEUTICALS, INC. | $37.93 | 1 |
| Neurocrine BioSciences, Inc. | $34.19 | 1 |
| Lundbeck LLC | $29.53 | 1 |
| MITSUBISHI TANABE PHARMA AMERICA, INC. | $29.52 | 1 |
| Stryker Corporation | $28.10 | 1 |
| EISAI INC. | $25.67 | 1 |
| Teva Pharmaceuticals USA, Inc. | $21.82 | 1 |
| Nevro Corp. | $21.61 | 1 |
| INSIGHTEC,INC | $21.50 | 1 |
| Lilly USA, LLC | $21.08 | 1 |
| Merz Pharmaceuticals, LLC | $19.83 | 1 |
| Abbott Laboratories | $17.52 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (33)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $17.52 | 12/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125345677 | CMS |
| ABBVIE INC. | $6.15 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106477330 | CMS |
| ABBVIE INC. | $23.86 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106477332 | CMS |
| ABBVIE INC. | $20.67 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106477334 | CMS |
| ABBVIE INC. | $24.60 | 05/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106477336 | CMS |
| ABBVIE INC. | $22.53 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106477338 | CMS |
| ABBVIE INC. | $24.05 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106477340 | CMS |
| ABBVIE INC. | $6.29 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106477342 | CMS |
| ABBVIE INC. | $22.27 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106477344 | CMS |
| ABBVIE INC. | $26.58 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106477346 | CMS |
| ABBVIE INC. | $26.82 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106477348 | CMS |
| ABBVIE INC. | $28.57 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106477350 | CMS |
| ABBVIE INC. | $24.35 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106477352 | CMS |
| Boston Scientific Corporation | $140.40 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092444582 | CMS |
| CATALYST PHARMACEUTICALS, INC. | $37.93 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144450004 | CMS |
| Eisai Inc. | $25.67 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110819439 | CMS |
| InSightec,Inc | $21.50 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110446661 | CMS |
| Lilly USA, LLC | $21.08 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135937992 | CMS |
| Lundbeck LLC | $29.53 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145991229 | CMS |
| Merz Pharmaceuticals, LLC | $19.83 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137959620 | CMS |
| MITSUBISHI TANABE PHARMA AMERICA, INC. | $29.52 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144506074 | CMS |
| Neurelis, Inc. | $20.32 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145660216 | CMS |
| Neurelis, Inc. | $21.24 | 12/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145660218 | CMS |
| Neurocrine Biosciences, Inc. | $34.19 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150932972 | CMS |
| Nevro Corp. | $21.61 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130782402 | CMS |
| PFIZER INC. | $18.28 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131168917 | CMS |
| PFIZER INC. | $20.26 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131168988 | CMS |
| PFIZER INC. | $22.14 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131402727 | CMS |
| PFIZER INC. | $22.86 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131843046 | CMS |
| Stryker Corporation | $28.10 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120026545 | CMS |
| Teva Pharmaceuticals USA, Inc. | $21.82 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151625774 | CMS |
| UCB, Inc. | $18.91 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143141599 | CMS |
| UCB, Inc. | $22.70 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143141603 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.